InsidersTradesSigma
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Browse the full record of transactions filed by Willard Stephen H. Officer active across 2 companies, notably NRX Pharmaceuticals, Inc.. In total, 4 disclosures have been recorded. Breakdown: 1 buy · 0 sell. Total volume traded: €55k. Activity tracked since 16 December 2022. The latest transaction was disclosed on 1 July 2026 (Retenue fiscale). Regulator: SEC (Form 4). All data is free.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
4 of 4 declarations
Willard Stephen H is a declarant linked to Longeveron Inc. and NRX Pharmaceuticals, Inc., where he is Chief Executive Officer and CHIEF EXECUTIVE OFFICER. Across 4 filings in total, the recent filings tracked cover the period from 2022-12-19 to 2026-07-06, with EUR 54978 of buys and EUR 0 of sells, and the most frequent transaction nature shown is tax withholding.